DE69614127D1 - Eine familie von verbindungen mit entzündungshemmender und antiviraler aktivität und deren zusammensetzungen alleine oder in verbindung mit inhibitoren der reversen transcriptase zur inhibierung, vermeidung oder eliminierung viraler replikation und methoden zu ihrer verwendung - Google Patents
Eine familie von verbindungen mit entzündungshemmender und antiviraler aktivität und deren zusammensetzungen alleine oder in verbindung mit inhibitoren der reversen transcriptase zur inhibierung, vermeidung oder eliminierung viraler replikation und methoden zu ihrer verwendungInfo
- Publication number
- DE69614127D1 DE69614127D1 DE69614127T DE69614127T DE69614127D1 DE 69614127 D1 DE69614127 D1 DE 69614127D1 DE 69614127 T DE69614127 T DE 69614127T DE 69614127 T DE69614127 T DE 69614127T DE 69614127 D1 DE69614127 D1 DE 69614127D1
- Authority
- DE
- Germany
- Prior art keywords
- inflammatory
- reverse transcriptase
- family
- inhibitors
- inhibit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52887995A | 1995-09-15 | 1995-09-15 | |
US08/600,525 US5705522A (en) | 1995-09-15 | 1996-02-13 | Compounds having anti-inflammatory and anti-viral activity, compositions of these, alone and in combination with reverse transcriptase inhibitors |
PCT/IB1996/000942 WO1997010205A1 (en) | 1995-09-15 | 1996-09-13 | A new family of compounds having anti-inflammatory and anti-viral activity and compositions of these, alone and in combination with reverse transcriptase inhibitors, for inhibiting, preventing or eliminating viral replication and methods of using same |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69614127D1 true DE69614127D1 (de) | 2001-08-30 |
Family
ID=27062862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69614127T Expired - Lifetime DE69614127D1 (de) | 1995-09-15 | 1996-09-13 | Eine familie von verbindungen mit entzündungshemmender und antiviraler aktivität und deren zusammensetzungen alleine oder in verbindung mit inhibitoren der reversen transcriptase zur inhibierung, vermeidung oder eliminierung viraler replikation und methoden zu ihrer verwendung |
Country Status (8)
Country | Link |
---|---|
US (1) | US5705522A (de) |
EP (1) | EP0854860B1 (de) |
JP (1) | JP2000511871A (de) |
AT (1) | ATE203513T1 (de) |
AU (1) | AU6835096A (de) |
CA (1) | CA2231996A1 (de) |
DE (1) | DE69614127D1 (de) |
WO (1) | WO1997010205A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002518452A (ja) * | 1998-06-24 | 2002-06-25 | エモリ ユニバーシティ | Hivの治療薬物の製造のための他の抗hiv薬と組み合わせた3’−アジド−2’,3’−ジデオキシウリジンの使用 |
JP2003523978A (ja) * | 2000-02-18 | 2003-08-12 | シャイアー・バイオケム・インコーポレイテッド | ヌクレオシドアナログを用いるflavivirus感染の処置もしくは予防するための方法 |
US20050087555A1 (en) * | 2003-10-28 | 2005-04-28 | Hatton Jason D. | Fluid dispensing components |
KR101423898B1 (ko) * | 2005-12-14 | 2014-07-28 | 암브룩스, 인코포레이티드 | 비-천연 아미노산 및 폴리펩티드를 함유하는 조성물, 비-천연 아미노산 및 폴리펩티드를 포함하는 방법, 및 비-천연 아미노산 및 폴리펩티드의 용도 |
LT2691530T (lt) | 2011-06-10 | 2018-08-10 | Oregon Health & Science University | Cmv glikoproteinai ir rekombinantiniai vektoriai |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0206497B1 (de) * | 1985-05-15 | 1994-07-20 | The Wellcome Foundation Limited | Therapeutische Nucleoside und deren Herstellung |
WO1987001284A1 (en) * | 1985-08-26 | 1987-03-12 | United States Of America, Represented By The Unite | Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxynosine, 2',3'-dideoxyguanosine, or 2',3'-dideoxyadenosine |
US5254539A (en) * | 1985-08-26 | 1993-10-19 | U.S. Government, Dept. Of Health And Human Services, C/O National Institutes Of Health | Method of treating HIV with 2',3'-dideoxyinosine |
US5571839A (en) * | 1989-04-28 | 1996-11-05 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | D-aspartic acid β-hydroxamate for the treatment of viral infections and tumors |
FR2646348A1 (fr) * | 1989-04-28 | 1990-11-02 | Inst Nat Sante Rech Med | D-aspartique acide-hydroxamate en tant que medicament |
GB9208428D0 (en) * | 1992-04-16 | 1992-06-03 | Proteus Molecular Design | Synthetic polypeptides |
ATE273700T1 (de) * | 1993-05-21 | 2004-09-15 | Us Gov Health & Human Serv | Neues verfahen zur hemmung der replication der virus - abhängigen reverse transciptase durch verwendung von dideoxydenucleotide-synthese inhibitoren |
AU1249595A (en) * | 1993-12-20 | 1995-07-17 | Compagnie De Developpment | Mixtures of dideoxynucleosides and d-aspartic acid beta-hydroxamate for inhibiting retroviral spread |
-
1996
- 1996-02-13 US US08/600,525 patent/US5705522A/en not_active Expired - Fee Related
- 1996-09-13 DE DE69614127T patent/DE69614127D1/de not_active Expired - Lifetime
- 1996-09-13 WO PCT/IB1996/000942 patent/WO1997010205A1/en active IP Right Grant
- 1996-09-13 JP JP09511797A patent/JP2000511871A/ja active Pending
- 1996-09-13 EP EP96928647A patent/EP0854860B1/de not_active Expired - Lifetime
- 1996-09-13 AU AU68350/96A patent/AU6835096A/en not_active Abandoned
- 1996-09-13 CA CA002231996A patent/CA2231996A1/en not_active Abandoned
- 1996-09-13 AT AT96928647T patent/ATE203513T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2000511871A (ja) | 2000-09-12 |
EP0854860B1 (de) | 2001-07-25 |
AU6835096A (en) | 1997-04-01 |
ATE203513T1 (de) | 2001-08-15 |
WO1997010205A1 (en) | 1997-03-20 |
US5705522A (en) | 1998-01-06 |
CA2231996A1 (en) | 1997-03-20 |
EP0854860A1 (de) | 1998-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0735890T3 (da) | Blandinger af 2',3'-dideoxyinosin og hydroxycarbamid til hæmning af retroviral spredning | |
DE3587434D1 (de) | Antivirale pharmazeutische zusammensetzungen und ihrer verwendung. | |
BG102048A (en) | Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors | |
KR880010777A (ko) | 바이러스 억제제와 결합한 dsRNA로 인간의 바이러스 감염을 치료하는 방법 | |
MX9403380A (es) | Inhibidores de proteasa de vih utiles para el tratamiento de sida. | |
DE3581819D1 (de) | Pyridazinamine wirksam gegen viren. | |
ATE298741T1 (de) | Polyaromatische verbindungen zur behandlung von herpes-infektionen | |
ATE227133T1 (de) | Verwendung von interferon-alpha 8 subtype zur herstellung von medikamenten zur behandlung von viralinfektionen der leber | |
ATE376445T1 (de) | Synergistische hemmung von viralreplikation durch langkettigen kohlenwasserstoffe und nucleosid- analoge | |
DK0706514T3 (da) | Forbindelser og fremgangsmåder til inhibering af HIV og relaterede vira | |
FI870377A0 (fi) | Antivirala kompositioner. | |
DE69614127D1 (de) | Eine familie von verbindungen mit entzündungshemmender und antiviraler aktivität und deren zusammensetzungen alleine oder in verbindung mit inhibitoren der reversen transcriptase zur inhibierung, vermeidung oder eliminierung viraler replikation und methoden zu ihrer verwendung | |
DE3686108D1 (de) | Verwendung von p-chlorophenoxyazetat von n,n-dimethylbiguanid zur behandlung von neuropathien und nervendegeneration. | |
AR009935A1 (es) | Un compuesto efectivo para inhibir aspartilproteasa, composiciones que lo incorporan y metodos para prevenir o tratar infecciones con hiv | |
KR890009389A (ko) | 바이러스를 억제시키는 방법 | |
ATE213231T1 (de) | Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren | |
ES2103577T3 (es) | Compuestos antiviricos de naftoquinona, composiciones que los contienen y utilizaciones de estos compuestos. | |
ES2113888T3 (es) | Sulfatos de dextrina como agentes anti hiv-1 y composicion de los mismos. | |
ES2134259T3 (es) | Compuestos antiviricos calanolidas, composiciones y utilizacion de los mismos. | |
PA8441101A1 (es) | Composiciones farmaceuticas | |
ATE179601T1 (de) | Aufheben der resistenz von hiv-1 linien gegenüber zidovudine | |
FR2647792B1 (de) | ||
ATE114115T1 (de) | Verwendung von 5,6-dihydro-dibenz(b,e>azepin-6,11-dion-11-oxim n zur herstellungvon antiretroviralen mitteln. | |
GR1000618B (el) | Μεθοδος αναστολης hiv χρησιμοποιωντας συνεργιστικους συνδυασμους νουκλεοσιδικων παραγωγων. | |
SE8106621L (sv) | Lekemedel med aktivitet mot orosneuros och orosliknande neuros och forfarande for framstellning derav |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |